WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 202
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 232

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Niue)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  22 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niue)
Vaccine year result method % card seen                                                
BCG          92  99*  99*  99*  99* 
DTP1          99*  99*  99*  99*  99* 
DTP3          99*  99*  99*  99  99* 
DTP4          99*  99* 
IPV1          99*  99* 
HepB_BD          99*  99*  99* 
HepB3          99*  99*  99*  99  99* 
Hib3          99*  99*  99*  99  99* 
JapEnc         
MCV1          99*  99*  99*  99*  99* 
MCV2          99*  99*  99*  98  99* 
MenA         
PCV1          99*  99*  99*  99* 
PCV2          99*  99*  99*  99 
PCV3          99*  99*  99*  99 
Pol3          99*  99*  99*  99  99* 
Rota1          74 
RotaC          74 
RCV1          99*  99*  99*  99* 
TT2plus         
PAB          99*  99* 
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niue)
BCG
ChartChart
  99  99  99  99  99  99  99  85 
DTP1
ChartChart
  99  99  99  99  99  99  99  27 
DTP3
ChartChart
  99  99  99  99  98  99  99 
HepB3
ChartChart
  99  99  99  99  98  99 
HepB_BD
ChartChart
  99  99  99  99  99  99 
Hib3
ChartChart
  99  99  99  99  99  99 
MCV1
ChartChart
  99  99  99  99  99  99  99  77 
MCV2
ChartChart
  99  99  99  99  98  99 
PCV3
ChartChart
  99  99  99  99  99 
Pol3
ChartChart
  99  99  99  99  98  99  99  76 
RCV1
ChartChart
  99  99  99  99  99  99  99  77 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.


Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes
HepB_Pediatric birth; Yes
HIB 15 months; Yes
Influenza_Adult 18 to +65 years; Yes and adults with chronic diseases, and health care workers, and Haj and travelers and other risk groups
Influenza_Pediatric Yes Children with chronic diseases
MMR 15 months; 4 years; Yes
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes
Rotavirus 6 weeks; 3, 5 months;
TdaPIPV 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes    No  Yes  Yes  Yes 
What years does the MYP cover? number   2011-2021          Annual 
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number      
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%       100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%       100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   No    Yes  Yes  Yes  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   No    No  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%          

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   No    Yes  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.